Patents by Inventor Roxanne N. Shurtliff

Roxanne N. Shurtliff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
    Patent number: 7074561
    Abstract: The present invention is directed to isothermal transcription based assays for the detection and quantification of alpha-fetoprotein (AFP) mRNA. The present invention is also directed to oligonucleotides for amplifying AFP mRNA and probes for use in the detection and quantification of the amplification product. The present invention is also directed to detecting hepatocellular carcinoma, metastasis thereof and tumor recurrence by analyzing peripheral blood for the presence of AFP mRNA.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: July 11, 2006
    Assignee: bioMerieux, Inc.
    Inventors: Roxanne N. Shurtliff, Eun Mi Lee
  • Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
    Publication number: 20040076962
    Abstract: The present invention is directed to isothermal transcription based assays for the detection and quantification of alpha-fetoprotein (AFP) mRNA. The present invention is also directed to oligonucleotides for amplifying AFP mRNA and probes for use in the detection and quantification of the amplification product. The present invention is also directed to detecting hepatocellular carcinoma, metastasis thereof and tumor recurrence by analyzing peripheral blood for the presence of AFP mRNA.
    Type: Application
    Filed: October 22, 2002
    Publication date: April 22, 2004
    Inventors: Roxanne N. Shurtliff, Eun Mi Lee
  • Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C
    Publication number: 20040018494
    Abstract: The present invention is directed to an isothermal transcription based assay for the detection and quantification of guanylyl cyclase C (GCC). The present invention is also directed to oligonucleotides for amplifying GCC RNA and probes for use in the detection and quantification of the amplification product. Finally, the present invention is directed to a method for detecting colon carcinoma, micrometastasis thereof and tumor recurrence by analyzing peripheral blood for the presence of GCC.
    Type: Application
    Filed: July 25, 2002
    Publication date: January 29, 2004
    Inventors: Roxanne N. Shurtliff, Eun Mi Lee, Joseph W. Romano